Search filters

Authors whose works are in public domain in at least one jurisdiction

List of works by Michael S Kostapanos

A 12-week, prospective, open-label analysis of the effect of rosuvastatin on triglyceride-rich lipoprotein metabolism in patients with primary dyslipidemia

scientific article published on 01 July 2007

Adding ezetimibe to statin treatment: is LDL-C lowering the only benefit?

scientific article published on November 2012

An overview of the extra-lipid effects of rosuvastatin.

scientific article published on 06 May 2008

Association between serum gamma-glutamyltransferase and acute ischemic nonembolic stroke in elderly subjects.

scientific article published in October 2009

Baseline triglyceride levels and insulin sensitivity are major determinants of the increase of LDL particle size and buoyancy induced by rosuvastatin treatment in patients with primary hyperlipidemia.

scientific article published on 7 June 2008

Benefit-risk assessment of rosuvastatin in the treatment of atherosclerosis and related diseases.

scientific article published on July 2014

Clinical relevance of central blood pressure - a critical review.

scientific article

Clopidogrel vs. aspirin treatment on admission improves 5-year survival after a first-ever acute ischemic stroke. data from the Athens Stroke Outcome Project.

scientific article

Colesevelam plus rosuvastatin 5 mg/day versus rosuvastatin 10 mg/day alone on markers of insulin resistance in patients with hypercholesterolemia and impaired fasting glucose.

scientific article

Comparison of the Pharmacokinetics of RIPK1 Inhibitor GSK2982772 in Healthy Western and Japanese Subjects

scientific article published on 09 November 2020

Comparison of the effects of simvastatin vs. rosuvastatin vs. simvastatin/ezetimibe on parameters of insulin resistance.

scientific article

Current role of fenofibrate in the prevention and management of non-alcoholic fatty liver disease

scientific article published on September 2013

Different definitions of the metabolic syndrome and risk of first-ever acute ischaemic non-embolic stroke in elderly subjects.

scientific article published in April 2007

Differential effect of hypolipidemic drugs on lipoprotein-associated phospholipase A2

scientific article published on 26 July 2007

Distinct effects of fixed combinations of valsartan with either amlodipine or hydrochlorothiazide on lipoprotein subfraction profile in patients with hypertension

scientific article published on 01 December 2011

Dose-dependent effect of rosuvastatin treatment on HDL-subfraction phenotype in patients with primary hyperlipidemia.

scientific article published in March 2009

Dose-dependent effect of rosuvastatin treatment on urinary protein excretion.

scientific article published in December 2007

Editorial: reducing cardiovascular risk: is low-density lipoprotein-cholesterol (LDL-C) lowering enough?

scientific article published on 01 March 2012

Effect of atorvastatin monotherapy and low-dose atorvastatin/ezetimibe combination on fasting and postprandial triglycerides in combined hyperlipidemia.

scientific article published on 23 April 2012

Effect of rifabutin on the pharmacokinetics of oral cabotegravir in healthy subjects

scientific article published on 01 January 2019

Effect of rosuvastatin monotherapy or in combination with fenofibrate or ω-3 fatty acids on lipoprotein subfraction profile in patients with mixed dyslipidaemia and metabolic syndrome

scientific article published on 01 September 2012

Effect of rosuvastatin treatment on plasma visfatin levels in patients with primary hyperlipidemia.

scientific article published on 2 October 2007

Effect of simvastatin/ezetimibe 10/10 mg versus simvastatin 40 mg on serum vitamin D levels

scientific article published on 02 January 2013

Effects of benchmarking on the quality of type 2 diabetes care: results of the OPTIMISE (Optimal Type 2 Diabetes Management Including Benchmarking and Standard Treatment) study in Greece.

scientific article published on October 2015

Effects of rosuvastatin combined with olmesartan, irbesartan, or telmisartan on indices of glucose metabolism in Greek adults with impaired fasting glucose, hypertension, and mixed hyperlipidemia: a 24-week, randomized, open-label, prospective study

scientific article published in March 2010

Emerging drugs for hyperlipidaemia: an update

scientific article published on 30 October 2014

Evaluation of the incidence and risk factors for development of fenofibrate-associated nephrotoxicity

scientific article published on 19 February 2012

Ezetimibe - a new approach in hypercholesterolemia management.

scientific article published in January 2012

Ezetimibe treatment lowers indicators of oxidative stress in hypercholesterolemic subjects with high oxidative stress

scientific article published on 26 February 2011

Fenofibrate and the kidney: an overview.

scientific article published on 11 March 2013

Gender differences in the epidemiology, clinical presentation, prevention, and prognosis of acute coronary syndromes

scientific article published on 01 January 2013

Hemostatic factors and the metabolic syndrome

scientific article published on 01 November 2013

How effective are the ESC/EAS and 2013 ACC/AHA guidelines in treating dyslipidemia? Lessons from a lipid clinic.

scientific article published on 24 November 2014

Hypertriglyceridaemic waist phenotype criteria and prevalent metabolic triad in women.

scientific article published in March 2008

Impact of renin-angiotensin-aldosterone system genes on the treatment response of patients with hypertension and metabolic syndrome.

scientific article published on December 2007

Lipid target achievement among patients with very high and high cardiovascular risk in a lipid clinic.

scientific article published on 15 May 2014

Low-dose interleukin-2 in patients with stable ischaemic heart disease and acute coronary syndromes (LILACS): protocol and study rationale for a randomised, double-blind, placebo-controlled, phase I/II clinical trial

scientific article published on 17 September 2018

Mechanisms linking nonalcoholic fatty liver disease with coronary artery disease

scientific article published on 07 February 2012

Mitochondrial triglyceride transfer protein inhibition: new achievements in the treatment of dyslipidemias.

scientific article published on January 2013

Modelling eating practices in non-fatal acute coronary syndrome or stroke development: a case/case-control study.

scientific article published on 28 March 2012

New-onset extremely low levels of high-density lipoprotein cholesterol

scientific article published on 04 July 2012

Obstructive sleep apnoea syndrome and cardiovascular risk.

scientific article published on 19 December 2012

Pioglitazone and cancer: angel or demon?

scientific article published on January 2013

Prevalence, Identification, and Scouting for Familial Hypercholesterolaemia including Registries

scientific article published on 01 January 2018

Recent developments in pharmacotherapy for hypertriglyceridemia: what's the current state of the art?

scientific article published on 18 November 2019

Rosuvastatin increases alpha-1 microglobulin urinary excretion in patients with primary dyslipidemia

scientific article published on 01 November 2006

Rosuvastatin treatment is associated with an increase in insulin resistance in hyperlipidaemic patients with impaired fasting glucose.

scientific article published in September 2009

Statins and mortality: the untold story.

scientific article

Statins and their increased risk of inducing diabetes

scientific article published on 05 October 2015

Targeting cardiovascular risk: the impact of age, gender and compliance to treatment

scientific article published on 02 August 2012

The effect of rosuvastatin on low-density lipoprotein subfractions in patients with impaired fasting glucose.

scientific article published on 18 September 2014

The effects of orlistat and fenofibrate, alone or in combination, on high-density lipoprotein subfractions and pre-beta1-HDL levels in obese patients with metabolic syndrome

scientific article published on 24 April 2007

Therapeutic options for statin-intolerant patients

scientific article published on 31 January 2012

Treating to target patients with primary hyperlipidaemia: comparison of the effects of ATOrvastatin and ROSuvastatin (the ATOROS study)

scientific article published on 01 June 2006

Variable effects of statins on glucose homeostasis parameters and their diabetogenic role.

scientific article

Paulina is supported by:

About Paulina

Help